Navigation Links
CABI helps phase out dangerous pesticide in EU
Date:9/12/2007

Methyl bromide is a highly toxic fumigant pesticide which is injected into soil to sterilise it before planting crops. It is also used as a post-harvest decontaminant of products and storage areas. Although it is highly effective in eradicating pests such as nematodes, weeds, insects and rodents, it depletes the ozone layer and poses a danger to human health.

The "Partners Award" forms part of the 20th anniversary of the Montreal Protocol - an agreement signed by more than 180 countries in 1987 - in a bid to stop the use of controlled ozone depleting substances.

It will be presented to CABI for identifying and documenting alternatives to replace methyl bromide, for implementing a system to transparently assess requests for its critical use and for supporting the development of a methyl bromide phase-out management strategy.

Methyl bromide was listed under the Montreal Protocol as a potentially dangerous pesticide. Dr Janny Vos, CABIs leading pesticide alternatives scientist, explains:

In the 1970s and 80s, growing evidence suggested that methyl bromide could cause damage to both the ozone layer and human health. Scientists found that occupational exposure to the substance could be linked to cancer. As a result, methyl bromide was banned under the Montreal Protocol in 1992.

All industrialised countries were asked to consent to phase out methyl bromide use by January 1st 2005. Developing countries were given until 2015.

However, although alternatives were found for more than 93% of the uses of methyl bromide, many countries claimed that because of regulatory restrictions, availability, cost and local conditions, they had little choice but to continue its use as a pest control. As a result they sought exemption for so-called critical use of methyl bromide from the protocol.

In order to help reduce the number of exemptions being awarded in the EU, CABI and its partners worked with the European Commission to develop and implement a system to assess requests for the critical use of methyl bromide, based on the Montreal Protocol as well as additional EC regulation.

CABI also looked at alternative practises around the globe, especially in countries that have similar climatic conditions to those requesting the continual use of methyl bromide. They presented countries with alternatives such as fumigants and chemicals, biocontrols and physical practices such as solarisation and steam treatment of the soil.

On CABIs collaboration with the European Commission, Dr Vos said:

We are extremely proud of the joint efforts of CABI and the European Commission to significantly reduce the usage of this Methyl Bromide in the EU. Our work will help set the precedence for reducing the use of methyl bromide in other parts of the world, and also for reducing reliance on other hazardous pesticides in the future.

Thanks to CABIs work, results have been impressive. In 2005, 5.7 million kg of methyl bromide was requested for critical usage by EU member states. In 2007 only 0.5 million kg was approved to five EU countries, with a majority of these pledging total elimination by 2008.


'/>"/>

Contact: Lynsey Sterrey
l.sterrey@cabi.org
44-149-182-9361
CABI
Source:Eurekalert

Related biology news :

1. Jumping gene helps explain immune systems abilities
2. Protein helps regulate the genes of embryonic stem cells
3. Scientists reveal the shape of a protein that helps retroviruses break into cells
4. Thai spice helps cut blood sugar swings
5. Newly Discovered Branding Process Helps Immune System Cells Pick Their Fights
6. Chemists synthesize molecule that helps body battle cancers, malaria
7. Ancient DNA helps clarify the origins of two extinct New World horse species
8. Massey Cancer Center researcher helps to identify a piece of the cancer puzzle
9. Study: Well-known protein helps stem cells become secretory cells
10. Beyond genes: Lipid helps cell wall protein fold into proper shape
11. Simple sea sponge helps scientists understand tissue rejection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
Breaking Biology News(10 mins):
(Date:5/19/2016)... ... May 19, 2016 , ... KCAS Bioanalytical and Biomarker Services, ... Director, Large Molecule & Biomarker Bioanalysis. , Dr. Siddiqui has more than 15 ... for preclinical and clinical safety programs. “We’ve seen significant demand for, and we ...
(Date:5/18/2016)... 2016 The Biotech industry continues to ... that there are no opportunities ahead. Today, ActiveWallSt.com has on ... THLD ), Seattle Genetics Inc. (NASDAQ: SGEN ... Corp. (NASDAQ: OPHT ). Sign up now to ... http://www.activewallst.com/ Threshold Pharmaceuticals Inc.,s shares gained ...
(Date:5/17/2016)... -- Haselmeier announces the launch by Merck ... EMA, the European Medicines Agency. Originally launched in 2011 ... new pen version includes enhancements to further improve the ... patients during use. Its enhanced design has ... with a larger display window that improves the readability ...
(Date:5/17/2016)... BASEL, Switzerland , May 17, 2016 /PRNewswire/ ... sciences company located in Basel, Switzerland ... an investigational oral inhibitor of P38 mitogen-activated protein ... ) , Strekin will build the ... Pamapimod in indications in which MAP Kinases play ...
Breaking Biology Technology: